Biggest OIS Ever Set to Deliver News & Insights

Biggest OIS Ever Set to Deliver News & Insights
The maturation and advance of the ophthalmology sector will be fully evident tomorrow as we host the largest Ophthalmology Innovation Summit in its seven-year history.

More than 900 clinicians, investors, and executives will descend upon the Planet Hollywood Hotel in Las Vegas to grab a glimpse of novel new treatments for ophthalmology disorders.

Three dozen biopharmaceutical, medtech, and digital health companies – public and private – will introduce themselves or provide updates to the most influential audience in ophthalmology.

The day remains a must attend event for innovators and entrepreneurs, who will receive invaluable advice on intellectual property protection and monetization while hearing from the leading VCs in ophthalmology.

But OIS also will recognize the maturation of the industry. For the first time, the conference will host a Public Company Showcase – giving the stage to six one-time start-ups that have gone public in recent years.

Following these presentations, OIS Co-Chair Emmett T. Cunningham Jr., MD, PhD, MPH, of Clarus Ventures, will lead a panel of Wall Street’s more adroit analysts in a discussion about market cycles and growth of the ophthalmology sector.

However, the news of the day may come from this year’s plenary address from Brent Saunders, CEO and president of Allergan. Allergan, of course, is flirting with Pfizer, hinting at a combination that could alter one of the more venerable names in ophthalmology.

Later, Saunders will join leaders from Alcon, Valeant/Bausch & Lomb, Johnson & Johnson Vision Care, Carl Zeiss Meditec AG, and Santen in the penultimate “Masters of the Universe” discussion led by James V. Mazzo, chairman and CEO of Acufocus, and OIS Co-Chair William J. Link, PhD, of Versant Ventures.

Co-Chair Gilbert H. Kliman, MD, of InterWest Partners will close out the day-long affair.

To register visit OIS.net or register tomorrow morning at the Planet Hollywood Hotel.

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

Glaukos' Bid for Avedro: What's Next

A Closer Look at Glaukos’ Bid for Avedro

OIS@ASRS Reporter's Notebook: Three Things Learned at OIS@ASRS About What Funders Want, Going Global, and AI

OIS@ASRS Reporter’s Notebook: Three Things Learned at OIS@ASRS About What Funders Want, Going Global, and AI

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

Recent Moves Show How Zeiss Is Positioning Itself for a New Era in Ophthalmology

National Vision and Eye Health Surveillance System Gears Up for September Launch

National Vision and Eye Health Surveillance System Gears Up for September Launch

OIS@ASRS at the Ritz-Carlton Chicago: An In-depth Look at the Retina Space

OIS@ASRS at the Ritz-Carlton Chicago: An In-depth Look at the Retina Space

About The Author

Tom Salemi

Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products. At Healthegy, Tom hosts the OIS Podcast and MedtechTalk, contributes to the Engage and Eye on Innovation newsletters and assists in the agenda development of new and existing conferences.

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.